… Efficient delivery of siRNA via nanoparticles emerged as a … various viral and nonviral delivery
systems, including different … a vector for brain gene therapy by integrating into the host cell …

… gene therapy may rescue cell death after central nervous system damage. We developed a
novel, non-viral gene therapy to block caspase-3 gene … polybutylcyanoacrylate nanoparticles …

… as a component of nanoparticle drug delivery; due to their … to treat areas of the central nervous
system. Systemic drugs … viral fragments along with a nonviral transporter. Pseudo virions …

… As a result, gene delivery into the CNS is largely dependent … of the therapeutic vector into
specific brain regions, eliminating … systemic delivery of lipid nanoparticles and other non-viral …

… based non-viral gene and drug delivery systems for brain cancer[J]. … and challenges in
developing nanoparticle- mediated drug delivery systems for the treatment of brain tumours[J/ …

… of the central nervous system, culminating in the arousal of neurodegenerative … non-viral
alternatives for gene delivery exist and include cationic lipid micelles and encapsulation inside …

… We highlighted the most salient reports focusing on GDNF gene therapy as a … Non-viral
gene delivery vehicles, such as naked DNA, RNA, liposomes, and nanoparticles, can harbor …

… Liposomes are a new type of non-viral vector, able to carry … results provide an experimental
basis for targeted gene therapy. … the treatment of central nervous system diseases. …

… effects on nervous system development. It is … non-viral gene delivery vectors still remains a
great challenge. In this study, we reported a new gene delivery vector based on nanoparticles …

… approach showing promise is gene therapy. In this systematic … Non-viral vectors including
liposomes and nanoparticles … in the CNS or primary sensory neurons and glial cells at the …